Healthcare Stocks Rise Despite Broad Market Selloff — Healthcare Roundup
The healthcare sector was one of the few to escape another losing day in U.S. stocks.
Grail received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test. The cancer-detection company said the FDA's medical devices advisory committee voted to greenlight a premarket approval application for Galleri. The FDA is expected to make its final ruling on Galleri's premarket approval in the coming months.
Interest in natural fibers such as cotton and wool is rising as people seek clothing that's safe and sustainable. But while natural fibers in many cases may use fewer chemicals than synthetics, a body of research is challenging whether they deserve a free pass. Scientists are finding chemicals in cotton and other natural-fiber clothing that, in studies not specific to apparel, have been shown to penetrate skin and cause health effects at sufficient exposures. Natural-fiber garments also shed microfibers that have been found in oceans and human lung tissue, can persist in the environment and have harmed marine organisms in laboratory studies.
Write to Paulo Trevisani at paulo.trevisani@wsj.com
(END) Dow Jones Newswires
September 24, 2026 17:49 ET (21:49 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
These Overvalued Stocks Have Plenty of Room to Fall
3 of the Best Dividend Stocks to Own
3 Stocks to Sell and 3 Stocks to Buy for November
4 Big Impacts from the US Midterm Elections for Investors
United States